Controlled Substance

Controlled Substance Seminar CME / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 2A (CSB2A) Topics Include:  Consensus Guidlines-Ketamine/Esketamine, Taper Chronic Use of Benzodiazepines, Patient Counseling, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Short Course:
CSB2A
Short Course Price:
$485
Format:
Available in Audio format.
Only Available Option: Short Course/Part A

Course Topics

Update on Ketamine and Esketamine

Explain the neurotrophic hypothesis of depression; Sketch the mechanism of action of ketamine and related agents; Summarize the findings of randomized trials that established the efficacy of ketamine and esketamine for treatment of depression; Select appropriate candidates for treatment of depression and suicidal ideation with ketamine or esketamine; Follow consensus guidelines when using ketamine or esketamine.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Perioperative Management for Orthopedic Surgery in the Patient Recovering from Opioid Addiction

Differentiate among options available for MAT; Make appropriate recommendations for discontinuation of MAT therapies prior to surgical procedures; Prescribe postoperative analgesia with the lowest risk for contributing to relapse of a patient who has recovered from opioid addiction; Identify signs of withdrawal from buprenorphine; Compare the efficacies and safety of medications used to ease perioperative pain and anxiety in patients who have recovered from opioid addiction.

QUALIFIES FOR PAIN MANAGEMENT-PM174, SUBSTANCE ABUSE, CONTROLLED SUBSTANCES

Opioids and Acute Pain

Educate patients on the potential for addiction when using opioid medications for analgesia; Recognize the complexities of providing analgesia to patients who are taking buprenorphine; Summarize the characteristics of ketamine; Describe advantages of using ultrasound-guided neurofascial plane nerve blocks; Counsel patients about postoperative pain to help set reasonable expectations.

QUALIFIES FOR PAIN MANAGEMENT-PM175, SUBSTANCE ABUSE, CONTROLLED SUBSTANCES

Role of Healthcare in Addressing the Opioid Crisis

Assist clinical leaders in combatting the opioid crisis; Foster collaboration among clinicians, health care systems, community organizations, and governments to address the opioid crisis; Describe the role of naloxone in caring for patients with opioid use disorder; Create an institutional protocol for consistently using the Screening, Brief Intervention, and Referral to Treatment tool; Encourage other clinicians to take ownership of the opioid crisis by educating themselves and obtaining the waivers required to provide medication-assisted treatment.

QUALIFIES FOR SUBSTANCE ABUSE AND CONTROLLED SUBSTANCES

Safe Deprescribing of Benzodiazepines

Identify appropriate and inappropriate uses of benzodiazepines; Select effective modalities to treat anxiety related to cognitive dysfunction; Recognize the symptoms of withdrawal from benzodiazepines; Consider pharmacokinetic and pharmacodynamics factors when planning withdrawal from benzodiazepines; Develop plans to taper chronic use of benzodiazepines.

QUALIFIES FOR GERIATRICS, CLINICAL PHARMACOLOGY AND CONTROLLED SUBSTANCES

Accreditation

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Internal MedicineOncologyPediatricsFamily PracticePsychology, and Psychiatry

If you have taken the current Controlled Substance CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

Specialty

video (mp4)